Suppr超能文献

子痫前期女性与无子痫前期的小于胎龄儿女性的“体内凝血酶生成”模式和程度有所不同。

The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.

作者信息

Erez Offer, Romero Roberto, Vaisbuch Edi, Kusanovic Juan Pedro, Mazaki-Tovi Shali, Chaiworapongsa Tinnakorn, Gotsch Francesca, Mittal Pooja, Edwin Samuel S, Nhan-Chang Chia-Ling, Than Nandor Gabor, Kim Chong Jai, Kim Sun Kwon, Yeo Lami, Mazor Moshe, Hassan Sonia S

机构信息

a Perinatology Research Branch , NICHD/NIH/DHHS , Bethesda , MD , USA.

b Department of Obstetrics and Gynecology , Wayne State University School of Medicine , Detroit , MI , USA.

出版信息

J Matern Fetal Neonatal Med. 2018 Jul;31(13):1671-1680. doi: 10.1080/14767058.2017.1323327. Epub 2017 May 23.

Abstract

OBJECTIVE

We aimed to determine the differences in the pattern and magnitude of thrombin generation between patients with preeclampsia (PE) and those with a small-for-gestational-age (SGA) fetus.

METHODS

This cross-sectional study included women in the following groups: (1) normal pregnancy (NP) (n = 49); (2) PE (n = 56); and (3) SGA (n = 28). Maternal plasma thrombin generation (TGA) was measured, calculating: (a) lag time (LT); (b) velocity index (VI); (c) peak thrombin concentration (PTC); (d) time-to-peak thrombin concentration (TPTC); and (e) endogenous thrombin potential (ETP).

RESULTS

(1) The median TPTC, VI, and ETP differed among the groups (p = .001, p = .006, p < .0001); 2) the median ETP was higher in the PE than in the NP (p < .0001) and SGA (p = .02) groups; 3) patients with SGA had a shorter median TPTC and a higher median VI than the NP (p = .002, p = .012) and PE (p < .0001, p = .006) groups.

CONCLUSIONS

(1) Patients with PE had higher in vivo thrombin generation than women with NP and those with an SGA fetus; (2) the difference in TGA patterns between PE and SGA suggests that the latter group had faster TGA, while patients with PE had a longer reaction, generating more thrombin. This observation is important for the identification of a subset of patients who might benefit from low molecular-weight heparin.

摘要

目的

我们旨在确定子痫前期(PE)患者与小于胎龄儿(SGA)胎儿患者之间凝血酶生成模式和程度的差异。

方法

这项横断面研究纳入了以下几组女性:(1)正常妊娠(NP)组(n = 49);(2)PE组(n = 56);(3)SGA组(n = 28)。测量母体血浆凝血酶生成(TGA),计算:(a)滞后时间(LT);(b)速度指数(VI);(c)凝血酶峰值浓度(PTC);(d)达到凝血酶峰值浓度的时间(TPTC);(e)内源性凝血酶潜力(ETP)。

结果

(1)各组间TPTC、VI和ETP的中位数存在差异(p = 0.001,p = 0.006,p < 0.0001);(2)PE组的ETP中位数高于NP组(p < 0.0001)和SGA组(p = 0.02);(3)SGA患者的TPTC中位数比NP组(p = 0.002,p = 0.012)和PE组(p < 0.0001,p = 0.006)短,VI中位数比NP组和PE组高。

结论

(1)PE患者的体内凝血酶生成高于NP女性和SGA胎儿女性;(2)PE和SGA之间TGA模式的差异表明,后一组的TGA更快,而PE患者的反应时间更长,产生的凝血酶更多。这一观察结果对于识别可能从低分子量肝素中获益的患者亚组很重要。

相似文献

1
The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.
J Matern Fetal Neonatal Med. 2018 Jul;31(13):1671-1680. doi: 10.1080/14767058.2017.1323327. Epub 2017 May 23.
2
Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.
J Matern Fetal Neonatal Med. 2018 Jun;31(12):1568-1577. doi: 10.1080/14767058.2017.1320543. Epub 2017 May 19.
4
Retinol binding protein 4--a novel association with early-onset preeclampsia.
J Perinat Med. 2010 Mar;38(2):129-39. doi: 10.1515/jpm.2009.140.
5
Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.
J Matern Fetal Neonatal Med. 2007 Sep;20(9):651-9. doi: 10.1080/14767050701463571.
9
Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia.
J Matern Fetal Neonatal Med. 2023 Dec;36(1):2153034. doi: 10.1080/14767058.2022.2153034. Epub 2022 Dec 15.
10
Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?
J Matern Fetal Neonatal Med. 2010 Aug;23(8):857-68. doi: 10.3109/14767050903301017.

引用本文的文献

1
First-Trimester Preeclampsia-Induced Disturbance in Maternal Blood Serum Proteome: A Pilot Study.
Int J Mol Sci. 2024 Oct 3;25(19):10653. doi: 10.3390/ijms251910653.
2
Classification of preeclampsia according to molecular clusters with the goal of achieving personalized prevention.
J Reprod Immunol. 2024 Feb;161:104172. doi: 10.1016/j.jri.2023.104172. Epub 2023 Nov 30.
3
Quantitative Proteomics of Maternal Blood Plasma in Isolated Intrauterine Growth Restriction.
Int J Mol Sci. 2023 Nov 27;24(23):16832. doi: 10.3390/ijms242316832.
4
Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia.
Blood Coagul Fibrinolysis. 2024 Jan 1;35(1):1-7. doi: 10.1097/MBC.0000000000001269. Epub 2023 Nov 30.
5
Laboratory Testing of Hemostasis in Pregnancy: A Brief Overview.
Methods Mol Biol. 2023;2663:111-125. doi: 10.1007/978-1-0716-3175-1_7.
8
Development and evaluation of a nomogram for adverse outcomes of preeclampsia in Chinese pregnant women.
BMC Pregnancy Childbirth. 2022 Jun 20;22(1):504. doi: 10.1186/s12884-022-04820-x.
9
Thrombosis and hemostasis health in pregnancy: Registries from the International Society on Thrombosis and Haemostasis.
Res Pract Thromb Haemost. 2019 Aug 1;3(4):607-614. doi: 10.1002/rth2.12243. eCollection 2019 Oct.
10
Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.
J Matern Fetal Neonatal Med. 2018 Jun;31(12):1568-1577. doi: 10.1080/14767058.2017.1320543. Epub 2017 May 19.

本文引用的文献

2
Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples.
PLoS One. 2016 May 19;11(5):e0154127. doi: 10.1371/journal.pone.0154127. eCollection 2016.
3
Thrombin generation, D-dimer and protein S in uncomplicated pregnancy.
Clin Chem Lab Med. 2015 Nov;53(12):1975-9. doi: 10.1515/cclm-2014-1030.
4
Tissue factor-dependent thrombin generation across pregnancy.
Am J Obstet Gynecol. 2012 Aug;207(2):135.e1-6. doi: 10.1016/j.ajog.2012.05.027. Epub 2012 Jun 11.
5
Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.
PLoS One. 2011;6(10):e26313. doi: 10.1371/journal.pone.0026313. Epub 2011 Oct 14.
6
High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.
J Matern Fetal Neonatal Med. 2010 Jan;23(1):23-33. doi: 10.3109/14767050902994770.
7
Platelet activation and endogenous thrombin potential in pre-eclampsia.
Thromb Res. 2010 Mar;125(3):e76-81. doi: 10.1016/j.thromres.2009.09.013. Epub 2009 Oct 12.
9
Tissue factor and its natural inhibitor in pre-eclampsia and SGA.
J Matern Fetal Neonatal Med. 2008 Dec;21(12):855-69. doi: 10.1080/14767050802361872.
10
A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
J Matern Fetal Neonatal Med. 2008 Oct;21(10):732-44. doi: 10.1080/14767050802361807.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验